The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats

Human histocompatibility leukocyte antigen B27 is highly associated with the rheumatic diseases termed spondyloarthropathies, but the mechanism is not known. B27 transgenic rats develop a spontaneous disease resembling the human spondyloarthropathies that includes arthritis and colitis. To investiga...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of experimental medicine Vol. 188; no. 5; pp. 877 - 886
Main Authors: Zhou, M, Sayad, A, Simmons, W A, Jones, R C, Maika, S D, Satumtira, N, Dorris, M L, Gaskell, S J, Bordoli, R S, Sartor, R B, Slaughter, C A, Richardson, J A, Hammer, R E, Taurog, J D
Format: Journal Article
Language:English
Published: United States The Rockefeller University Press 07-09-1998
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Human histocompatibility leukocyte antigen B27 is highly associated with the rheumatic diseases termed spondyloarthropathies, but the mechanism is not known. B27 transgenic rats develop a spontaneous disease resembling the human spondyloarthropathies that includes arthritis and colitis. To investigate whether this disease requires the binding of specific peptides to B27, we made a minigene construct in which a peptide from influenza nucleoprotein, NP383-391 (SRYWAIRTR), which binds B27 with high affinity, is targeted directly to the ER by the signal peptide of the adenovirus E3/gp19 protein. Rats transgenic for this minigene, NP1, were made and bred with B27 rats. The production of the NP383-391 peptide in B27(+)NP1(+) rats was confirmed immunologically and by mass spectrometry. The NP1 product displaced approximately 90% of the 3H-Arg-labeled endogenous peptide fraction in B27(+)NP1(+) spleen cells. Male B27(+)NP1(+) rats had a significantly reduced prevalence of arthritis, compared with B27(+)NP- males or B27(+) males with a control construct, NP2, whereas colitis was not significantly affected by the NP1 transgene. These findings support the hypothesis that B27-related arthritis requires binding of a specific peptide or set of peptides to B27, and they demonstrate a method for efficient transgenic targeting of peptides to the ER.
AbstractList Human histocompatibility leukocyte antigen B27 is highly associated with the rheumatic diseases termed spondyloarthropathies, but the mechanism is not known. B27 transgenic rats develop a spontaneous disease resembling the human spondyloarthropathies that includes arthritis and colitis. To investigate whether this disease requires the binding of specific peptides to B27, we made a minigene construct in which a peptide from influenza nucleoprotein, NP383-391 (SRYWAIRTR), which binds B27 with high affinity, is targeted directly to the ER by the signal peptide of the adenovirus E3/gp19 protein. Rats transgenic for this minigene, NP1, were made and bred with B27 rats. The production of the NP383-391 peptide in B27+NP1+ rats was confirmed immunologically and by mass spectrometry. The NP1 product displaced ∼90% of the 3H-Arg-labeled endogenous peptide fraction in B27+NP1+ spleen cells. Male B27+NP1+ rats had a significantly reduced prevalence of arthritis, compared with B27+NP− males or B27+ males with a control construct, NP2, whereas colitis was not significantly affected by the NP1 transgene. These findings support the hypothesis that B27-related arthritis requires binding of a specific peptide or set of peptides to B27, and they demonstrate a method for efficient transgenic targeting of peptides to the ER.
Human histocompatibility leukocyte antigen B27 is highly associated with the rheumatic diseases termed spondyloarthropathies, but the mechanism is not known. B27 transgenic rats develop a spontaneous disease resembling the human spondyloarthropathies that includes arthritis and colitis. To investigate whether this disease requires the binding of specific peptides to B27, we made a minigene construct in which a peptide from influenza nucleoprotein, NP383-391 (SRYWAIRTR), which binds B27 with high affinity, is targeted directly to the ER by the signal peptide of the adenovirus E3/gp19 protein. Rats transgenic for this minigene, NP1, were made and bred with B27 rats. The production of the NP383-391 peptide in B27(+)NP1(+) rats was confirmed immunologically and by mass spectrometry. The NP1 product displaced approximately 90% of the 3H-Arg-labeled endogenous peptide fraction in B27(+)NP1(+) spleen cells. Male B27(+)NP1(+) rats had a significantly reduced prevalence of arthritis, compared with B27(+)NP- males or B27(+) males with a control construct, NP2, whereas colitis was not significantly affected by the NP1 transgene. These findings support the hypothesis that B27-related arthritis requires binding of a specific peptide or set of peptides to B27, and they demonstrate a method for efficient transgenic targeting of peptides to the ER.
Human histocompatibility leukocyte antigen B27 is highly associated with the rheumatic diseases termed spondyloarthropathies, but the mechanism is not known. B27 transgenic rats develop a spontaneous disease resembling the human spondyloarthropathies that includes arthritis and colitis. To investigate whether this disease requires the binding of specific peptides to B27, we made a minigene construct in which a peptide from influenza nucleoprotein, NP383-391 (SRYWAIRTR), which binds B27 with high affinity, is targeted directly to the ER by the signal peptide of the adenovirus E3/gp19 protein. Rats transgenic for this minigene, NP1, were made and bred with B27 rats. The production of the NP383-391 peptide in B27 super(+)NP1 super(+) rats was confirmed immunologically and by mass spectrometry. The NP1 product displaced similar to 90% of the super(3)H-Arg-labeled endogenous peptide fraction in B27 super(+)NP1 super(+) spleen cells. Male B27 super(+)NP1 super(+) rats had a significantly reduced prevalence of arthritis, compared with B27 super(+)NP super(-) males or B27 super(+) males with a control construct, NP2, whereas colitis was not significantly affected by the NP1 transgene. These findings support the hypothesis that B27-related arthritis requires binding of a specific peptide or set of peptides to B27, and they demonstrate a method for efficient transgenic targeting of peptides to the ER.
Human histocompatibility leukocyte antigen B27 is highly associated with the rheumatic diseases termed spondyloarthropathies, but the mechanism is not known. B27 transgenic rats develop a spontaneous disease resembling the human spondyloarthropathies that includes arthritis and colitis. To investigate whether this disease requires the binding of specific peptides to B27, we made a minigene construct in which a peptide from influenza nucleoprotein, NP383-391 (SRYWAIRTR), which binds B27 with high affinity, is targeted directly to the ER by the signal peptide of the adenovirus E3/gp19 protein. Rats transgenic for this minigene, NP1, were made and bred with B27 rats. The production of the NP383-391 peptide in B27 + NP1 + rats was confirmed immunologically and by mass spectrometry. The NP1 product displaced ∼90% of the 3 H-Arg-labeled endogenous peptide fraction in B27 + NP1 + spleen cells. Male B27 + NP1 + rats had a significantly reduced prevalence of arthritis, compared with B27 + NP − males or B27 + males with a control construct, NP2, whereas colitis was not significantly affected by the NP1 transgene. These findings support the hypothesis that B27-related arthritis requires binding of a specific peptide or set of peptides to B27, and they demonstrate a method for efficient transgenic targeting of peptides to the ER.
Author Sayad, A
Slaughter, C A
Maika, S D
Richardson, J A
Taurog, J D
Dorris, M L
Simmons, W A
Gaskell, S J
Bordoli, R S
Satumtira, N
Jones, R C
Sartor, R B
Hammer, R E
Zhou, M
AuthorAffiliation From the Harold C. Simmons Arthritis Research Center and Department of Internal Medicine; ‡ Howard Hughes Medical Institute and Department of Biochemistry; § Department of Pediatrics and ‖ Department of Pathology, University of  Texas Southwestern Medical Center, Dallas, Texas 75235; ¶ Department of Chemistry, UMIST, Manchester, United Kingdom; Micromass Ltd, Wythenshawe, Manchester, United Kingdom; and the †† Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599
AuthorAffiliation_xml – name: From the Harold C. Simmons Arthritis Research Center and Department of Internal Medicine; ‡ Howard Hughes Medical Institute and Department of Biochemistry; § Department of Pediatrics and ‖ Department of Pathology, University of  Texas Southwestern Medical Center, Dallas, Texas 75235; ¶ Department of Chemistry, UMIST, Manchester, United Kingdom; Micromass Ltd, Wythenshawe, Manchester, United Kingdom; and the †† Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599
Author_xml – sequence: 1
  givenname: M
  surname: Zhou
  fullname: Zhou, M
  organization: Harold C. Simmons Arthritis Research Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235, USA
– sequence: 2
  givenname: A
  surname: Sayad
  fullname: Sayad, A
– sequence: 3
  givenname: W A
  surname: Simmons
  fullname: Simmons, W A
– sequence: 4
  givenname: R C
  surname: Jones
  fullname: Jones, R C
– sequence: 5
  givenname: S D
  surname: Maika
  fullname: Maika, S D
– sequence: 6
  givenname: N
  surname: Satumtira
  fullname: Satumtira, N
– sequence: 7
  givenname: M L
  surname: Dorris
  fullname: Dorris, M L
– sequence: 8
  givenname: S J
  surname: Gaskell
  fullname: Gaskell, S J
– sequence: 9
  givenname: R S
  surname: Bordoli
  fullname: Bordoli, R S
– sequence: 10
  givenname: R B
  surname: Sartor
  fullname: Sartor, R B
– sequence: 11
  givenname: C A
  surname: Slaughter
  fullname: Slaughter, C A
– sequence: 12
  givenname: J A
  surname: Richardson
  fullname: Richardson, J A
– sequence: 13
  givenname: R E
  surname: Hammer
  fullname: Hammer, R E
– sequence: 14
  givenname: J D
  surname: Taurog
  fullname: Taurog, J D
BackLink https://www.ncbi.nlm.nih.gov/pubmed/9730889$$D View this record in MEDLINE/PubMed
BookMark eNqFkUFvFSEUhYmpqa_VpUsTVsYu5gkD84CNSdtYa_ISN3VNGOZOhzoDIzBN3m_xz8rYl0ZXLggh97vnHHLO0IkPHhB6S8mWEsk_PsC0pVJum60U4gXa0IaTSjVMnqANIXVdUULEK3SW0gMhlPNmd4pOlWBESrVBv-4GwGkG63pnXT7g0OMZ5uw6SLgNi-9wDnhYJuPx4FIONkyzya5140qPsPwI9pABG5_dPXj84XZ_eVFd1QI7348LeFuEcjGZIzyacX2vHibmIbrsUsFwWfmzkaPxqYg4i6PJ6TV62ZsxwZvjfY6-33y-u76t9t--fL2-3FeWU5arloKVxpQjGZOkExR4S9tGmFbtmG1Ja4ngvFas77ls6obLjnXKcFDMSKrYOfr0pDsv7QSdBV-CjHqObjLxoINx-t-Jd4O-D4-6runqWATeHwVi-LlAynpyycI4Gg9hSVowxXa0pPsfSHcNJbwWBayeQBtDShH65zSU6LV2XWrXpXbd6FJ74d_9_YVn-tgz-w1EZ63N
CitedBy_id crossref_primary_10_1034_j_1399_0039_2003_00074_x
crossref_primary_10_1110_ps_8_7_1393
crossref_primary_10_4049_jimmunol_163_12_6665
crossref_primary_10_3389_fimmu_2022_902135
crossref_primary_10_1097_00002281_199907000_00006
crossref_primary_10_1515_labm_1999_23_9_485
crossref_primary_10_1034_j_1399_0039_2002_600301_x
crossref_primary_10_4049_jimmunol_169_7_4033
crossref_primary_10_1002_ajp_20139
crossref_primary_10_1016_S1471_4914_03_00029_7
crossref_primary_10_4049_jimmunol_163_4_2299
crossref_primary_10_1016_S0002_9629_15_40415_X
crossref_primary_10_1002_eji_200323678
crossref_primary_10_4049_jimmunol_173_8_4859
crossref_primary_10_1016_S0167_5699_00_01625_X
crossref_primary_10_1046_j_1365_2249_2001_01440_x
crossref_primary_10_1016_S1357_4310_00_01699_3
crossref_primary_10_1007_s11926_996_0011_9
crossref_primary_10_1016_S0889_857X_03_00050_4
crossref_primary_10_1111_j_1399_0039_2008_01051_x
crossref_primary_10_4049_jimmunol_166_5_3334
crossref_primary_10_4049_jimmunol_167_10_5543
crossref_primary_10_1007_s11926_000_0066_y
crossref_primary_10_3109_08830180009048388
crossref_primary_10_1146_annurev_immunol_032414_112110
crossref_primary_10_1074_jbc_M308816200
crossref_primary_10_4049_jimmunol_173_11_6564
crossref_primary_10_1016_S1357_4310_98_01375_6
crossref_primary_10_1136_annrheumdis_2012_203080
crossref_primary_10_1074_jbc_M205470200
crossref_primary_10_1002_1529_0131_199909_42_9_1975__AID_ANR25_3_0_CO_2_V
crossref_primary_10_1111_j_1600_065X_1999_tb01317_x
crossref_primary_10_1128_IAI_72_9_5097_5105_2004
crossref_primary_10_2217_ijr_12_84
crossref_primary_10_1038_ncprheum0219
crossref_primary_10_4049_jimmunol_170_2_1099
crossref_primary_10_1093_intimm_13_10_1275
crossref_primary_10_1007_s11926_004_0055_7
crossref_primary_10_4049_jimmunol_167_8_4738
crossref_primary_10_1074_jbc_M108882200
crossref_primary_10_1007_s11926_999_0029_x
Cites_doi 10.1146/annurev.iy.07.040189.003125
10.4049/jimmunol.159.6.2750
10.1007/BF00210477
10.1111/j.1600-065X.1996.tb00932.x
10.4049/jimmunol.150.9.4168
10.1084/jem.182.4.1153
10.1016/0167-5699(96)80605-0
10.1111/j.1399-0039.1997.tb02713.x
10.1016/S0952-7915(98)80033-2
10.1016/0092-8674(90)90512-D
10.1111/j.1399-0039.1997.tb02724.x
10.1111/j.1399-0039.1997.tb02741.x
10.1002/j.1460-2075.1989.tb03431.x
10.1084/jem.178.5.1607
10.1146/annurev.iy.12.040194.001145
10.1084/jem.174.2.489
10.1172/JCI118878
10.1146/annurev.iy.13.040195.001305
10.1016/0167-5699(90)90051-A
10.1084/jem.180.6.2359
10.1128/iai.64.1.120-127.1996
10.1002/eji.1830270205
10.1016/0161-5890(92)90046-Z
10.1093/intimm/2.4.311
10.1002/eji.1830251133
10.1016/S1074-7613(00)80385-4
10.1016/S0952-7915(96)80106-3
10.4049/jimmunol.156.2.794
10.1146/annurev.iy.11.040193.003501
10.4049/jimmunol.156.4.1661
10.1073/pnas.90.14.6879
10.1084/jem.181.5.1597
10.1002/bms.1200160119
10.1016/S1074-7613(00)80680-9
ContentType Journal Article
Copyright 1998
Copyright_xml – notice: 1998
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
H94
7X8
5PM
DOI 10.1084/jem.188.5.877
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1540-9538
EndPage 886
ExternalDocumentID 10_1084_jem_188_5_877
9730889
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: T32 CA009082
– fundername: NCI NIH HHS
  grantid: CA09082-20
– fundername: NIAMS NIH HHS
  grantid: 1 R01 AR38319
– fundername: NIAMS NIH HHS
  grantid: R01 AR038319
GroupedDBID ---
-~X
.55
.GJ
0VX
18M
29K
2WC
36B
3O-
4.4
53G
5GY
5RE
5VS
9M8
ABOCM
ABZEH
ACGFO
ACNCT
ACPRK
ADBBV
AENEX
AFFNX
AFOSN
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C45
CGR
CS3
CUY
CVF
D-I
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
EMB
F5P
F9R
FRP
GX1
H13
HYE
H~9
IH2
K-O
KQ8
L7B
MVM
N9A
NPM
O5R
O5S
OK1
P2P
P6G
R.V
RHF
RHI
RPM
SJN
TR2
TRP
UHB
VH1
W8F
WOQ
X7M
ZGI
AAYXX
CITATION
7T5
H94
7X8
5PM
ID FETCH-LOGICAL-c413t-b1ec8aac8a83380d71e4b1b57ab963cb0bc0744293ff4852548d3d9a4e93a8193
IEDL.DBID RPM
ISSN 0022-1007
IngestDate Tue Sep 17 21:27:26 EDT 2024
Sat Oct 26 01:28:40 EDT 2024
Sat Oct 05 04:54:58 EDT 2024
Thu Nov 21 20:39:12 EST 2024
Sat Nov 02 12:31:05 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c413t-b1ec8aac8a83380d71e4b1b57ab963cb0bc0744293ff4852548d3d9a4e93a8193
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Address correspondence to Joel D. Taurog, M.D., Harold C. Simmons Arthritis Research Center, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-8884. Phone: (214) 648-6837; Fax: (214) 648-3783; E-mail: taurog@utsw.swmed.edu
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213380/
PMID 9730889
PQID 16510427
PQPubID 23462
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2213380
proquest_miscellaneous_73936183
proquest_miscellaneous_16510427
crossref_primary_10_1084_jem_188_5_877
pubmed_primary_9730889
PublicationCentury 1900
PublicationDate 1998-09-07
PublicationDateYYYYMMDD 1998-09-07
PublicationDate_xml – month: 09
  year: 1998
  text: 1998-09-07
  day: 07
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of experimental medicine
PublicationTitleAlternate J Exp Med
PublicationYear 1998
Publisher The Rockefeller University Press
Publisher_xml – name: The Rockefeller University Press
References 12458560 - NIH Guide Grants Contracts. 2000 Sep 12;:OD-00-052
J Exp Med 2000 Feb 21;191(4):following 746
López de Castro (2023072508155244100_B1) 1998; 10
2023072508155244100_B28
Benjamin (2023072508155244100_B5) 1990; 11
Taurog (2023072508155244100_B13) 1993; 150
Carreno (2023072508155244100_B23) 1992; 29
Garcia (2023072508155244100_B37) 1997; 49
Rock (2023072508155244100_B27) 1996; 17
Hammer (2023072508155244100_B15) 1990; 63
Rath (2023072508155244100_B25) 1996; 98
Powis (2023072508155244100_B40) 1996; 4
Khare (2023072508155244100_B11) 1995; 182
Engelhard (2023072508155244100_B26) 1994; 12
Nasution (2023072508155244100_B36) 1997; 24
Burmester (2023072508155244100_B6) 1995; 13
Taurog (2023072508155244100_B29) 1996; 39
Parham (2023072508155244100_B32) 1996; 54
Fiorillo (2023072508155244100_B38) 1997; 27
Ren (2023072508155244100_B35) 1997; 49
Simmons (2023072508155244100_B17) 1997; 159
Simmons (2023072508155244100_B24) 1997; 7
Colbert (2023072508155244100_B22) 1993; 90
Gonzalez-Roces (2023072508155244100_B33) 1997; 49
Breban (2023072508155244100_B9) 1996; 156
Lehner (2023072508155244100_B4) 1996; 8
Taurog (2023072508155244100_B14) 1994; 180
2023072508155244100_B12
Pircher (2023072508155244100_B21) 1989; 8
D'Amato (2023072508155244100_B34) 1995; 25
Biemann (2023072508155244100_B41) 1988; 16
2023072508155244100_B2
Huet (2023072508155244100_B20) 1990; 2
Simmons (2023072508155244100_B10) 1996; 156
Huang (2023072508155244100_B7) 1996; 64
Sercarz (2023072508155244100_B31) 1993; 11
Wucherpfennig (2023072508155244100_B39) 1995; 181
Wold (2023072508155244100_B19) 1989; 6
Taurog (2023072508155244100_B30) 1994; 37
Townsend (2023072508155244100_B3) 1989; 7
Simmons (2023072508155244100_B16) 1993; 38
Anderson (2023072508155244100_B18) 1991; 174
Breban (2023072508155244100_B8) 1993; 178
References_xml – volume: 7
  start-page: 601
  year: 1989
  ident: 2023072508155244100_B3
  article-title: Antigen recognition by class I-restricted T lymphocytes
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.iy.07.040189.003125
  contributor:
    fullname: Townsend
– volume: 159
  start-page: 2750
  year: 1997
  ident: 2023072508155244100_B17
  article-title: Novel HY peptide antigens presented by HLA-B27
  publication-title: J Immunol
  doi: 10.4049/jimmunol.159.6.2750
  contributor:
    fullname: Simmons
– volume: 38
  start-page: 351
  year: 1993
  ident: 2023072508155244100_B16
  article-title: Sharing of an HLA-B27-restricted H-Y antigen by rat and mouse
  publication-title: Immunogenetics
  doi: 10.1007/BF00210477
  contributor:
    fullname: Simmons
– volume: 37
  start-page: S223
  year: 1994
  ident: 2023072508155244100_B30
  article-title: The inflammatory disease of HLA-B27 rats: evidence for the specificity of B27
  publication-title: Arthritis Rheum
  contributor:
    fullname: Taurog
– volume: 54
  start-page: 137
  year: 1996
  ident: 2023072508155244100_B32
  article-title: Presentation of HLA class I-derived peptides: potential involvement in allorecognition and HLA-B27-associated arthritis
  publication-title: Immunol Rev
  doi: 10.1111/j.1600-065X.1996.tb00932.x
  contributor:
    fullname: Parham
– volume: 150
  start-page: 4168
  year: 1993
  ident: 2023072508155244100_B13
  article-title: Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression
  publication-title: J Immunol
  doi: 10.4049/jimmunol.150.9.4168
  contributor:
    fullname: Taurog
– volume: 39
  start-page: S121
  year: 1996
  ident: 2023072508155244100_B29
  article-title: Alleles of the inbred dark agouti (DA) rat strain are protective against inflammatory disease in HLA-B27 transgenic rats
  publication-title: Arthritis Rheum
  contributor:
    fullname: Taurog
– volume: 182
  start-page: 1153
  year: 1995
  ident: 2023072508155244100_B11
  article-title: Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking β2-microglobulin: a model of human spondyloarthropathies
  publication-title: J Exp Med
  doi: 10.1084/jem.182.4.1153
  contributor:
    fullname: Khare
– volume: 17
  start-page: 131
  year: 1996
  ident: 2023072508155244100_B27
  article-title: A new foreign policy—MHC class I molecules monitor the outside world
  publication-title: Immunol Today
  doi: 10.1016/0167-5699(96)80605-0
  contributor:
    fullname: Rock
– volume: 49
  start-page: 67
  year: 1997
  ident: 2023072508155244100_B35
  article-title: Possible protective role of HLA-B*2706 for ankylosing spondylitis
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.1997.tb02713.x
  contributor:
    fullname: Ren
– volume: 10
  start-page: 59
  year: 1998
  ident: 2023072508155244100_B1
  article-title: The pathogenetic role of HLA-B27 in chronic arthritis
  publication-title: Curr Opin Immunol
  doi: 10.1016/S0952-7915(98)80033-2
  contributor:
    fullname: López de Castro
– ident: 2023072508155244100_B28
– volume: 63
  start-page: 1099
  year: 1990
  ident: 2023072508155244100_B15
  article-title: Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2-m: an animal model of HLA-B27-associated human disorders
  publication-title: Cell
  doi: 10.1016/0092-8674(90)90512-D
  contributor:
    fullname: Hammer
– volume: 49
  start-page: 116
  year: 1997
  ident: 2023072508155244100_B33
  article-title: HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.1997.tb02724.x
  contributor:
    fullname: Gonzalez-Roces
– volume: 49
  start-page: 215
  year: 1997
  ident: 2023072508155244100_B37
  article-title: Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated with ankylosing spondylitis
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.1997.tb02741.x
  contributor:
    fullname: Garcia
– volume: 8
  start-page: 719
  year: 1989
  ident: 2023072508155244100_B21
  article-title: T cell tolerance to Mlsaencoded antigens in T cell receptor Vβ8.1 chain transgenic mice
  publication-title: EMBO (Eur Mol Biol Organ) J
  doi: 10.1002/j.1460-2075.1989.tb03431.x
  contributor:
    fullname: Pircher
– volume: 178
  start-page: 1606
  year: 1993
  ident: 2023072508155244100_B8
  article-title: Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment
  publication-title: J Exp Med
  doi: 10.1084/jem.178.5.1607
  contributor:
    fullname: Breban
– volume: 12
  start-page: 181
  year: 1994
  ident: 2023072508155244100_B26
  article-title: Structure of peptides associated with class I and class II MHC molecules
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.iy.12.040194.001145
  contributor:
    fullname: Engelhard
– volume: 6
  start-page: 433
  year: 1989
  ident: 2023072508155244100_B19
  article-title: Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor
  publication-title: Mol Biol Med
  contributor:
    fullname: Wold
– volume: 174
  start-page: 489
  year: 1991
  ident: 2023072508155244100_B18
  article-title: Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis
  publication-title: J Exp Med
  doi: 10.1084/jem.174.2.489
  contributor:
    fullname: Anderson
– volume: 98
  start-page: 945
  year: 1996
  ident: 2023072508155244100_B25
  article-title: Normal luminal bacteria, especially bacteroides species, mediate chronic colonic, gastric, and systemic inflammation in HLA-B27/hβ2m transgenic rats
  publication-title: J Clin Invest
  doi: 10.1172/JCI118878
  contributor:
    fullname: Rath
– volume: 13
  start-page: 229
  year: 1995
  ident: 2023072508155244100_B6
  article-title: Immunology of reactive arthritides
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.iy.13.040195.001305
  contributor:
    fullname: Burmester
– volume: 24
  start-page: 1111
  year: 1997
  ident: 2023072508155244100_B36
  article-title: HLA-B27 subtypes positively and negatively associated with spondyloarthropathy
  publication-title: J Rheumatol
  contributor:
    fullname: Nasution
– volume: 11
  start-page: 137
  year: 1990
  ident: 2023072508155244100_B5
  article-title: Guilt by association: HLA-B27 and ankylosing spondylitis
  publication-title: Immunol Today
  doi: 10.1016/0167-5699(90)90051-A
  contributor:
    fullname: Benjamin
– volume: 180
  start-page: 2359
  year: 1994
  ident: 2023072508155244100_B14
  article-title: The germfree state prevents development of gut and joint inflammatory disease in HLA-B27transgenic rats
  publication-title: J Exp Med
  doi: 10.1084/jem.180.6.2359
  contributor:
    fullname: Taurog
– volume: 64
  start-page: 120
  year: 1996
  ident: 2023072508155244100_B7
  article-title: A patient-derived cytotoxic T-lymphocyte clone and two peptide-dependent monoclonal antibodies recognize HLA-B27-peptide complexes with low stringency for peptide sequences
  publication-title: Infect Immun
  doi: 10.1128/iai.64.1.120-127.1996
  contributor:
    fullname: Huang
– volume: 27
  start-page: 368
  year: 1997
  ident: 2023072508155244100_B38
  article-title: Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes
  publication-title: Eur J Immunol
  doi: 10.1002/eji.1830270205
  contributor:
    fullname: Fiorillo
– volume: 29
  start-page: 1131
  year: 1992
  ident: 2023072508155244100_B23
  article-title: The peptide binding specificity of HLA class I molecules is largely allele-specific and non-overlapping
  publication-title: Mol Immunol
  doi: 10.1016/0161-5890(92)90046-Z
  contributor:
    fullname: Carreno
– volume: 2
  start-page: 311
  year: 1990
  ident: 2023072508155244100_B20
  article-title: Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27
  publication-title: Int Immunol
  doi: 10.1093/intimm/2.4.311
  contributor:
    fullname: Huet
– volume: 25
  start-page: 3199
  year: 1995
  ident: 2023072508155244100_B34
  article-title: Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis
  publication-title: Eur J Immunol
  doi: 10.1002/eji.1830251133
  contributor:
    fullname: D'Amato
– volume: 7
  start-page: 641
  year: 1997
  ident: 2023072508155244100_B24
  article-title: A new MHC locus that influences class I peptide presentation
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80385-4
  contributor:
    fullname: Simmons
– volume: 8
  start-page: 59
  year: 1996
  ident: 2023072508155244100_B4
  article-title: Processing and delivery of peptides presented by MHC class I molecules
  publication-title: Curr Opin Immunol
  doi: 10.1016/S0952-7915(96)80106-3
  contributor:
    fullname: Lehner
– volume: 156
  start-page: 794
  year: 1996
  ident: 2023072508155244100_B9
  article-title: T cells but not thymic exposure to HLA-B27 are required for the inflammatory disease of HLA-B27 transgenic rats
  publication-title: J Immunol
  doi: 10.4049/jimmunol.156.2.794
  contributor:
    fullname: Breban
– volume: 11
  start-page: 729
  year: 1993
  ident: 2023072508155244100_B31
  article-title: Dominance and crypticity of T cell antigenic determinants
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.iy.11.040193.003501
  contributor:
    fullname: Sercarz
– volume: 156
  start-page: 1661
  year: 1996
  ident: 2023072508155244100_B10
  article-title: Rat MHC-linked peptide transporter alleles strongly influence peptide binding by HLA-B27 but not B27-associated inflammatory disease
  publication-title: J Immunol
  doi: 10.4049/jimmunol.156.4.1661
  contributor:
    fullname: Simmons
– ident: 2023072508155244100_B12
– volume: 90
  start-page: 6879
  year: 1993
  ident: 2023072508155244100_B22
  article-title: Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.90.14.6879
  contributor:
    fullname: Colbert
– volume: 181
  start-page: 1597
  year: 1995
  ident: 2023072508155244100_B39
  article-title: Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases
  publication-title: J Exp Med
  doi: 10.1084/jem.181.5.1597
  contributor:
    fullname: Wucherpfennig
– volume: 16
  start-page: 99
  year: 1988
  ident: 2023072508155244100_B41
  article-title: Contributions of mass spectrometry to peptide and protein structure
  publication-title: Biomed Environ Mass Spectrom
  doi: 10.1002/bms.1200160119
  contributor:
    fullname: Biemann
– ident: 2023072508155244100_B2
– volume: 4
  start-page: 159
  year: 1996
  ident: 2023072508155244100_B40
  article-title: The rat cimeffect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER
  publication-title: Immunity
  doi: 10.1016/S1074-7613(00)80680-9
  contributor:
    fullname: Powis
SSID ssj0014456
Score 1.8209558
Snippet Human histocompatibility leukocyte antigen B27 is highly associated with the rheumatic diseases termed spondyloarthropathies, but the mechanism is not known....
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 877
SubjectTerms Amino Acid Sequence
Animals
Animals, Genetically Modified
Arthritis - epidemiology
Arthritis - genetics
Arthritis - immunology
Base Sequence
Chromatography, High Pressure Liquid
Cytotoxicity, Immunologic - genetics
Female
Gene Expression Regulation - immunology
HLA-B27 Antigen - genetics
HLA-B27 Antigen - metabolism
Humans
Influenza A virus - genetics
Male
Mass Spectrometry
Molecular Sequence Data
Nucleocapsid Proteins
Nucleoproteins - biosynthesis
Nucleoproteins - genetics
Nucleoproteins - immunology
Peptide Fragments - genetics
Peptide Fragments - immunology
Peptide Fragments - metabolism
Prevalence
Protein Binding - genetics
Protein Binding - immunology
Rats
Rats, Inbred Lew
Rats, Sprague-Dawley
RNA-Binding Proteins
T-Lymphocytes, Cytotoxic - immunology
Transgenes - immunology
Viral Core Proteins - biosynthesis
Viral Core Proteins - genetics
Viral Core Proteins - immunology
Title The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats
URI https://www.ncbi.nlm.nih.gov/pubmed/9730889
https://search.proquest.com/docview/16510427
https://search.proquest.com/docview/73936183
https://pubmed.ncbi.nlm.nih.gov/PMC2213380
Volume 188
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xlUC9VOVRsaXAHBCCQ7KbxImd47a0WqQtqnhI3CLH9qoL3aRqsof9LfxZZpykakHiwCEnx3bkGXvGmW--AXhDRmWZZ3EUxKWLA5FFWUB6QwIxKZnLLLeJ59mef5GfvqsPp0yTkw65MB60b8pVWF2tw2p16bGV12szGXBik4vzkzjmm9V0MoIR-YbDFb0PHQjhS7Z6mDpDAHpizakSkx9uHUZKhWmopNyFhzmpt-IC73dN0l9-5p9wyTv252wf9nrHEWfdBz6GB656Ao_O-9D4U_hFAkdfTZ45Idot1ku8YMiKdQ0ec_EkbGv0_-zRc4N49HnbgWO3uHCbn7XZtg5nVcsMnfhuvpi9D45jiR-HQiYNkruIzPqkfa4Sz0EfdOmJkXBFAy9mvoe3gDTIyuBn3TbP4NvZ6deTedBXXggMGbU2KCNnlNb0KF5oKyMnyqhMpS5pw5pyWhpyPciUJculUCldMpVNbK6FyxNNPkZyADtVXbnngCrViWDSnFRZYadOx1IqYyxzMaosycbwdlj84roj2Ch8YFyJguRVkLyKtCB5jeH1IJqCtgDHNXTl6k1TRBkdLCL-xxtM-5fR4TWGg06Ut1P1KjAGeU_Gt-3Mvn2_hZTSs3D3Snj43z1fwG6X4MhZZEew095s3EsYNXbzymv0bwfC-sM
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4VKgqXtrSgbinFB4TaQ7J5OLFzXF5aRBYhSqXeLMf2iqXdBDXZw_6W_lnGToKglXrgkJPjRzRjzzjzzTcA-2hUplkahV5UmMijaZh6qDcoEJWguUwzHTue7fE3dvGDH59Ympykz4VxoH1VzPzy19wvZzcOW3k3V8MeJza8nBxFkb1ZBcMVeIn7NQj6S3oXPKDUFW11QHULAuioNQNOh7dm7oec-4nPGduAtQwVnNsS74-N0j-e5t-AyUcW6PTNM9f-Fl53LicZtc2b8MKU7-DVpAuqv4c_qCrE1aG3bBLNklRTcmnBLtrU5NCWXSJNRdzffuJYRRxuvWlhtUuSm8XPSi0bQ0ZlY7k9yZdxPvrqHUaMnPUlUGqCjiaxfFHSZTnZOXBBN45Sicxw4HzkejjbiYPMFLmSTb0F309Pro_GXlezwVNoDhuvCI3iUuLD7WdqFhpahEXCZIFbXRVBodBpQSMYT6eUJ3g95TrWmaQmiyV6J_E2rJZVaT4A4YmMqaXbSbimOjAyYowrpS2LI0_jdAAHvdDEXUvNIVxInVOBchYoZ5EIlPMA9nqRCtw8NiIiS1MtahGmeCTR6D9vWMLAFI-9AWy3KvAwVac6A2BPdOOh3fJ2P21BlXD83Z0KfHx2zz1YH19PcpGfXZzvwEabJmlz0T7BavN7YXZhpdaLz25X3APPnhBN
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JbtswEB00KRrk0j2ou4WHomgP2ihKpI7OYjioExhdgN4EiqQQp7FkRPLB39Kf7ZCSjKQFemgPOlFchJnhDDWPbwDeoVMps5RGHi0M9VgapR7qDQpEJegu00zHjmd7-oVffBcnp5YmZ1vqy4H2VbHwq-ulXy0uHbZytVTBgBML5ufHlNqTVRisdBnswH202ZAOB_U-gcCYK9zqwOoWCNDTa4aCBVdm6UdC-IkvON-HBxkqubBl3m87pj-izd9Bk7e80OTRf6z_MTzsQ08y7l55AvdM9RT2zvvk-jP4iSpDXD16yyrRbkhdkrkFvWjTkCNbfom0NXF__YljF3H49baD127IzKx_1GrTGjKuWsvxST5MZ-OP3hHl5GwohdIQDDiJ5Y2S7raTnQMXdOmolcgCB56NXQ_nQ3GQhSKfZds8h2-T06_HU6-v3eApdIutV0RGCSnxEfZTNY8MK6Ii4bJAk1dFWCgMXtAZxmXJRILHVKFjnUlmslhilBIfwG5VV-YFEJHImFnanURopkMjKedCKW3ZHEUapyN4PwguX3UUHblLrQuWo6xzlHWe5CjrERwOYs3RiGxmRFamXjd5lOLWxOhf3rDEgSlufyM46NRgO1WvPiPgd_Rj2275u--2oFo4Hu9eDV7-c89D2JufTPLZ2cWnV7Df3Za0V9Jew257szZvYKfR67fOMH4BW-cSzQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Specificity+of+Peptides+Bound+to+Human+Histocompatibility+Leukocyte+Antigen+%28HLA%29-B27+Influences+the+Prevalence+of+Arthritis+in+HLA-B27+Transgenic+Rats&rft.jtitle=The+Journal+of+experimental+medicine&rft.au=Zhou%2C+Ming&rft.au=Sayad%2C+A&rft.au=Simmons%2C+WA&rft.au=Jones%2C+R+C&rft.date=1998-09-07&rft.issn=0022-1007&rft.volume=188&rft.issue=5&rft.spage=877&rft.epage=886&rft_id=info:doi/10.1084%2Fjem.188.5.877&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1007&client=summon